VCAIX yields 2.83% · MRK yields 3.25%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, VCAIX + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of VCAIX + MRK for your $10,000?
The fund’s investment objective is to seek to provide a higher level of current income than shorter-term bonds, but with less share-price fluctuation than longer-term bonds. The fund is intended for California residents only. It invests primarily in high-quality municipal bonds issued by California state and local governments, as well as by regional government and public financing authorities. Under normal circumstances, at least 80% of the fund’s assets will be invested in securities whose income is exempt from federal and California state taxes. Although the fund has no limitations on the maturities of individual securities, its dollar-weighted average maturity is expected to be between 6 and 12 years. Risks of the fund include the fact that changes in interest rates, both up and down, can affect the fund by resulting in lower bond prices or an eventual decrease in income for the fund. Investors who are looking for a fund that may provide federal and California state tax-exempt interest income and can tolerate moderate price and income fluctuations may wish to consider this fund.The Vanguard California Intermediate-Term Tax-Exempt Fund is a stand alone product and is separate and distinct from the Vanguard California Tax-Exempt Bond ETF (VTEC). Differences in scale, certain investment processes, and underlying holdings are expected to produce different investment returns by the funds.
Full VCAIX Calculator →Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.